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and Boris Tabakoff
Background: Alcohol has been shown to critically modulate cyclic adenosine-3=,5= monophosphate (cAMP) signaling. A number of
downstream effectors that respond to the cAMP signals (e.g., protein kinase A, cAMP response element binding protein) have, in turn, been
examined in relation to alcohol consumption. These studies did not, however, delineate the point at which the actions of alcohol on the
cAMPcascademight translate intodifferences indrinkingbehavior. To further understand the role of cAMPsynthesis in alcohol drinking and
dependence, we investigated a specific adenylyl cyclase isoform, adenylyl cyclase (AC) Type 7, whose activity is selectively enhanced by
ethanol.
Methods: Wemeasured alcohol consumption and preference in mice in which one copy of the Adcy7 gene was disrupted (Adcy7/). To
demonstrate relevance of this gene for alcohol dependence in humans,we tested the association of polymorphisms in theADCY7genewith
alcohol dependence in a sample of 1703 alcohol-dependent individuals and 1347 control subjects.
Results: We show that Adcy7/ female mice have higher preference for alcohol than wild-type mice, whereas there is little difference in
alcohol consumptionorpreferencebetweenAdcy7/malemice andwild-type control subjects. In thehuman sample,we found that single
nucleotide polymorphisms in ADCY7 associate with alcohol dependence in women, and these markers are also associated with ADCY7
expression (messenger RNA) levels.
Conclusions: These findings implicate adenylyl cyclase Type 7 as a critical component of the molecular pathways contributing to alcohol
drinking and the development of alcohol dependence.
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C yclic adenosine-3=,5= monophosphate (cAMP) is an intracel-lular second messenger that mediates signaling generatedby activation of numerous G protein-coupled receptors. Cy-
lic AMP is formed from adenosine triphosphate by the action of
arious isoforms of the enzyme adenylyl cyclase (AC), each ofwhich
s specifically regulated by G proteins, calcium, and other modula-
ors (1). Within the cell, changes in cAMP levels affect the activity of
rotein kinaseA (PKA) and subsequently thedownstreamtargets of
KA, including cAMP response element binding protein (CREB), a
ranscription factor that regulates the expression of numerous
enes (2).
Alcohol dependence is a psychiatric disorder that is influenced
y both genetic and environmental factors (3,4). Evidence suggests
5) that there are numerous gene/proteins and gene  environ-
ent interactions that influence the degree of alcohol consump-
ion. There is a significant amountof animal literature thatdescribes
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or example, it has been reported that CREB and phosphorylated
activated) CREB are lower in the amygdaloid structures of lines of
ats selectively bred for alcohol preference (P rats) and that acute
xposure of these rats to alcohol increased the levels of phosphor-
lated CREB (9). In addition, infusion of a PKA inhibitor into the
entral amygdaloid nucleus of P rats decreased phosphorylated
REB levels and resulted in increased alcohol consumption (9).
nfusion of a PKA inhibitor into the nucleus accumbens of Sprague–
awley rats also increased alcohol consumption (10). Moreover,
KA mutant mice (lacking the RII regulatory subunit of PKA) had
ower cAMP-stimulated PKA activity in brain and displayed higher
evels of voluntary alcohol consumption than wild-type (WT) mice
11). These data indicate that lower brain levels of the downstream
ignaling proteins of the AC-cAMP pathway might contribute to
ncreased alcohol consumption (although one study found lower
lcohol consumption in mice with low Gs  or PKA levels in brain
12).
However, surprisingly little attention has focused on the role of
Cs, the family of enzymes that produce cAMP, inmodulating alco-
ol-drinking behavior. Animal studies have shown that cAMP levels
nd certain isoforms of AC play a role in sensitivity to the acute
edative and ataxic effects of ethanol (13–15). In humans, it has
een suggested that low platelet AC activity levels might be a
enetic marker of a predisposition to alcohol dependence (16–18).
Our studies of the acute stimulatory effect of alcohol on recep-
or-activated AC activity showed that the AC7 isoform is the most
ensitive to alcohol (19). This isoform of AC is found in human
rythroleukemia cells, which are derived from platelet precursor
ells (20,21) and might therefore be an important factor when
latelet AC activity is measured in humans. To determine whether
he ethanol-sensitive AC7 isoform influences alcohol drinking, we
ssessed voluntary alcohol intake and preference in mice that are
BIOL PSYCHIATRY 2011;69:1100–1108
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S. Desrivières et al. BIOL PSYCHIATRY 2011;69:1100–1108 1101genetically deficient in AC7 (22). We also evaluated genetic poly-
morphisms in the human AC7 gene (ADCY7) that could affect AC7
protein levels in a population of alcohol-dependent subjects, given
that differences in AC7 expression levels and therefore activity
might affect the level of alcohol drinking in humans as well as in
mice.
Methods andMaterials
Animals
Experiments were performed on 90–120-day-old mice. The
Adcy7 heterozygous “knockdown” mice, in which one copy of the
Adcy7 gene was disrupted (Adcy7/) (22), were backcrossed to
C57BL/6 mice for 13–15 generations or to 129S6/SvEv mice for
13–14 generations (disruption of both copies of the Adcy7 gene
produced death in the fetus). The respective littermates were used
as control subjects (WT). The animalswere housed in a colony room
with 12-hour light/12-hour dark cycle with controlled temperature
(23°C) andhumidity (40%). Access to foodandwaterwas ad libitum.
All efforts were made to minimize any potential suffering, and all
experimental procedures were approved by the University of Colo-
rado Denver Institutional Animal Care and Use Committee.
Two-Bottle Choice Ethanol Consumption
Animals from both genetic backgrounds (C57BL/6 and 129S6/
SvEv) were used and tested in separate experiments. Mice were
singly housed for 4 days before the experiment with continuous
access to two drinking tubes containing tap water only, to reduce
stress and acclimatize the animals. On the fifth day, one drinking
tube was filled with a solution containing ethanol. The concentra-
tion of ethanol was increased every fourth day (3%, 5%, 7%, 10%,
and 14%, v/v). Drinking tubepositionwas changed every other day,
and ethanol andwater consumptionweremeasured every day. The
average ethanol consumption (g/kg/day) and the preference ratio
for ethanol (ethanol volume/total fluid volume consumed) from
each of the 4 day sessions was used for the analysis.
Analysis of Mouse Alcohol Drinking Data
Themouse drinking data are presented asmean SEM. Alcohol
drinking data were analyzed with a repeatedmeasures 2-way anal-
ysis of variancewith a heterogeneous variance structure to account
for difference in variance across ethanol concentration. Degrees of
freedom for all tests were estimated with the Kenward-Roger cor-
rection. Means and SEMs shown in Figure 1 were calculated with
the least squares method. Between-group comparisons were per-
formed with linear contrasts within the repeated measures 2-way
analysis of variance. The analyses were carried out with the MIXED
procedure in SAS (SAS Institute, Cary, North Carolina). p values of
.05 were considered statistically significant.
Alcohol-Dependent Patients
Seventeen hundred three patients (1349men, 354women)meet-
ing criteria of alcohol dependence according to DSM-IV and ICD-10
were recruited from an inpatient abstention program after detoxifica-
tion at the Department of Psychiatry at Regensburg University. All
participants were of German descent, with parents living in Bavaria
and participants themselves born and raised in this area. Written in-
formed consent was obtained for all participants before the study.
Patients were assessed by trained staff who rated participants inde-
pendently with a structured interview on the basis of the substance
abuse section of the Munich-Composites International Diagnostic In-
terview (23). Patients with a lifetime history of schizophrenia or an
addiction to drugs other than tobacco or alcohol were excluded from bhe study. Participants were screened for neurological and psychiatric
isorders with self-report questionnaires adapted from the German
ersion of the inventory to diagnose depression (24); alcohol con-
umption levels during the past 30 days were determined with the
lcohol Use Disorders Identification Test (25) or the time-line-follow
ack(26).Phenotypicdescriptionofthesepatients isdisplayedinTable
. Analyses performed in this study arebasedon1213 individuals (290
omen and 923men) for whomgenotyping data were available (de-
ails in the following text).
ontrol Subjects
Thirteen hundred forty-seven individuals (714 men, 633
omen) from the region of Bonn, Germany, were recruited from
001 to 2003within the German National Research Project to serve
s control subjects for genetic studies in several neuropsychiatric
henotypes. Population-based recruitment was performed in col-
aborationwith the local censusbureau. Participantswere screened
orneurological andpsychiatric disorderswith self-report question-
aires adapted from the German version of the inventory to diag-
ose depression (24,27); smoking and drinking were diagnosed
ith the Fagerstrom Tolerance Questionnaire (28) and the alcohol
se disorder identification test (25). More than 96% of the partici-
ants were of German or Western European origin as ascertained
y place of birth of their grandparents. Written informed consent
as obtained before study participation.
ingle Nucleotide Polymorphism Selection,
enotyping, and Statistical Analysis
Genomic DNA was extracted from whole blood with standard
ethods andquantified in the Laboratory at the Central Institute of
ental Health Molecular Genetics Laboratory. Seven single nucle-
tide polymorphisms (SNPs) that captured 74% of HapMap alleles
t the ADCY7 locus on chromosome 16 at r2 .8 were selected for
enotyping. Single nucleotide polymorphisms were genotyped
ith the TaqMan MGB biallelic discrimination system. Probes and
rimers were ordered from and automatically designed by Applied
iosystems (Foster City, California) with the Assay-by-Design prod-
ct. Polymerase chain reactions were performed in Biometra T1
hermocyclers, and fluorescence was measured with an ABI Prism
900HT sequence-detector end point read. Genotyping errors and
onsistency across plates were checked with four common control
amples/plate. Process and genotyping datawere exported into an
nternal laboratory information management system. Case-control
nalyses were conducted to examine allelic association between
NPs andalcohol dependence (categorical variableDSM-IVdiagno-
is) with PLINK v1.06 (http://pngu.mgh.harvard.edu/purcell/
link/) (29). Thresholds for filters were .01 for allele frequency, .1 for
issingness/individual, .1 for missingness/marker, and .05 for Har-
y–Weinberg equilibrium. Empiric significance levels were ob-
ained after 10,000 permutations.
xpression Quantitative Trait Loci Analyses in Blood
nd Adipose Tissues
The correlation between rs2302717 and the level ofADCY7mes-
enger RNA (mRNA) was tested in a dataset that includes measure-
ents of the expression of 23,720 transcripts in adipose tissue and
n whole blood from 674 and 1002 Icelandic individuals, respec-
ively. The collection of the tissue samples and themeasurement of
he expressionwere described previously (30). Of those individuals,
06 with adipose tissue samples and 747 with blood samples had
een genotyped with the Illumina 317K or 370K chip, and because
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wrs2302717 is not included on those SNP chips, these genotypes
were used to impute genotypes for rs2302717 on the basis of the
HapMap CEU (r22) dataset with the IMPUTE program (31). The cor-
relation between ADCY7mRNA levels and rs2302717was tested by
egressing the adjusted and inverse normal transformedmean log-
rithm (log ) expression ratio on the number of copies of the risk
Figure 1. Ethanol-drinking patterns in Adcy7/mice on the C57BL/6 (A) an
%–14%ethanol inwater solution) weremeasured by the two-bottle free-ch
C57BL/6: females, n
 6;males, n
 11;WT, females n
 8,males n
 8; Adcy
Values represent the mean SEM in each group. *p .02; Hp .1, compar10
variant a person carries. For adipose tissue, the expression was n
ww.sobp.org/journaldjusted for age and gender of the individuals, and for blood the
xpressionwas also adjusted for differential cell count. To adjust for
he relatedness of individuals in the expression dataset, the 	2
tatistic was divided by the adjustment factors 1.063 and 1.078 for
dipose tissue and blood, respectively. These adjustment factors
ere determined by simulation on the basis of the known related-
956/SvEv (B) backgrounds. Daily ethanol consumption and preference (for
paradigm inmale and femaleAdcy7/ andwild-type (WT)mice (Adcy7/
12956/SvEv: females n
 9,males n
 7;WT, females n
 14,males, n
 10).
th WT.d 12
oice
/ess of the individuals as described previously (32). The gene ex-
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All patients expressed signs of severe alcohol dependence with daily
drinking and loss of control.
S. Desrivières et al. BIOL PSYCHIATRY 2011;69:1100–1108 1103ression data are available from theGEOdatabase under the acces-
ion numbers GSE7965 and GPL3991.
esults
lcohol Preference and Intake by Adcy7/ andWTMice
We compared ethanol consumption and preference of
dcy7/ and WT mice in a two-bottle choice alcohol-drinking
aradigm. Differences in alcohol consumption and preference be-
ween Adcy7/ animals and their respective WT control subjects,
n twogenetic backgrounds (C57BL/6or 129S6/SvEv), are shown in
igure 1. Female WT mice on the C57BL/6 background showed
elatively high ethanol preference, in the range of 70%–80%. There
as a trend toward an effect of genotype on alcohol preference in
hese mice [F (1,11.3) 
 4.39, p 
 .059]. Post hoc linear contrasts
howed that preference was significantly higher in the Adcy7/
emale mice, compared withWT, at 5% ethanol (p
 .007), and was
lso higher at 3% (p
 .088) and 7% (p
 .061) ethanol. Inmalemice
n the C57BL/6 background, there was a trend toward a genotype
lcohol concentration interactionwith respect to alcohol consump-
ion [F (4.235)
 2.2, p
 .097], but the post hoc comparisons were
ot statistically significant.
Unaltered female WT mice on the 129S6/SvEv background
howed lower alcohol preference (in the range of 20%–40%) than
ice on the C57BL/6 background. For these mice, there were sig-
ificant genotype (deletion of one copy of Adcy7) concentration
nteractions both for alcohol consumption [F (4,34.7) 
 5.61, p 

0001] and for alcohol preference [F (4,33.3) 
 5.1, p 
 .003]. The
dcy7/ mice consumed more alcohol at the 10% (p 
 .01) and
4% (p 
 .004) concentrations and also displayed higher prefer-
nce at these concentrations (10%,p
 .021; 14%,p
 .02). Formale
ice on the 129S6/SvEv background, there was a trend toward a
enotype  concentration interaction for alcohol consumption
F (4,24.1)
 2.41, p
 .077], but in juxtaposition to femalemice, the
dcy7/malemice consumed less alcohol than theWTmice at the
4% concentration (p
 .005).
ssociation of ADCY7Genotypes with Alcohol Dependence
n Humans
We hypothesized that variations in the ADCY7 gene in humans
ight also confer susceptibility to differences in alcohol consump-
ion, which could affect the development of dependence. We ana-
yzed associationof SNPswithinADCY7with alcohol dependence in
sample of 1703 alcohol-dependent patients and 1347 control
ubjects. Seven haplotype-tagging SNPs were genotyped and
ested for association with alcohol dependence. We performed the
nalysis in males and females separately, given the reported sex-
pecific role of this gene in humans (22) and our results with the
enetically modifiedmice. The SNP rs2302717 had themost signif-
cant, sex-specific association with alcohol dependence (Table 2),
nd this association remained significant after 10,000permutations
p
 .0139 after permutations). Its minor allele (T) was less frequent
mong alcoholic females than nonalcoholic females. An odds ratio
f .71 (95%confidence interval: .54–.93) suggests that the T allele at
s2302717 reduces the risk to develop alcohol dependence by a
actor of approximately 1.4 in females. Relative positions of the
NPs genotyped and their linkage disequilibrium (LD) patterns in
ur sample are shown in Table 3. Haplotype blocks estimation
evealed two 2-SNP haplotypes formed by rs2302717/rs7191958
nd rs1872691/rs1064448, respectively. Analysis of common hap-
otypes (frequency  .01) within the rs2302717/rs7191958 block
ndicated that the minor alleles at these SNPs always co-occurredTable 1. Phenotypic Characterization of the Alcohol-Dependent Patient
Sample
Variables n SD
Number of Patients
All 1703
Women 354 (20.8%)
Men 1349 (79.2%)
Age
All 43.3  9.9
Women 44.4  10.0
Men 42.9  10.0
Number of Criteria
ICD-10:
All 5.4  .9
Women 5.3  1.0
Men 5.4  .9
DSM-IV:
All 6.0  1.2
Women 5.0  1.3
Men 6.0  1.2
Age at Begin of Specific Symptoms
Consumption Alcohol Regularly:
All 20.8  8.5
Women 25.3  10.6
Men 19.4  7.3
Begin Loss of Control:
All 28.1  10.6
Women 33.1  10.9
Men 26.7  10.1
Begin Tolerance:
All 29.5  10.3
Women 34.7  10.2
Men 28.0  9.8
Begin Withdrawal:
All 34.5  10.3
Women 38.1  10.1
Men 33.4  10.2
First Inpatient Treatment:
All 39.2  10.3
Women 40.4  10.5
Men 38.8  10.2
Amount of Alcohol Consumption (gm)
Daily:
All 206.1  114.1
Women 166.7  96.03
Men 218.1  116.5
“Record” in the last 30 Days Before
Inpatient Treatment:
All 296.2  151.9
Women 226.1  125.1
Men 316.4  153.1
Smoking (investigated n
 1248)
Smokers:
All 970 (77.7%)
Women 208 (71.7% of women)
Men 762 (79.5% of men)
Number of Cigarettes/Day:
All 25.9  11.5
Women 23.6  11.3
Men 26.5  11.5n the same haplotype (observed frequencies for rs2302717/
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wrs7191958 haplotypes: T/A, .176; C/A, .124; C/G, .696). This indicates
that the TAhaplotype formedby the combinationof rs2302717and
rs7191958 is responsible for the observed associationswith alcohol
dependence in our sample.
The SNPmost associated with alcohol dependence (rs2302717)
is located in intron five of the ADCY7 gene and is in high LD with
several markers at the 5= region of the ADCY7 gene (Figure 2B).
Notably, it completely tags rs1078151, which is located 4007 base
pairs upstream of the first exon (complete LD [r2 
 1] between
rs2302717 and rs1078151). The location of rs1078151 and its LD
with rs2302717 suggested that the minor allele at rs2302717 (and
rs1078151) might correlate with changes in ADCY7 gene expres-
sion. To test this, we analyzed whether rs2302717 correlated with
ADCY7 mRNA levels in large population-based blood and adipose
tissue cohorts for which genotypes and global gene expression
data were available (30). These expression quantitative trait loci
analyses revealed that theminor allele at rs2302717 correlatedwith
lower ADCY7mRNA levels in both tissues (effect estimates [SEM], p
value:.212 [.071], .0039 and.231 [.068], .001, for adipose tissue
and blood, respectively) (Figure 3). These data suggest that geno-
type at rs2302717 might correlate with ADCY7mRNA expression.
Discussion
Our findings provide the first evidence for a role for ADCY7 in
evelopment of alcohol dependence in women. Although be-
avioral experiments using genetically modified mice demon-
Table 2. Association of ADCY7with Alcohol Dependence in Humans
SNP BP Minor Allele MAF in Cases MAF in C
Females (279 cases, 573 control subjects)
rs7202127 48,882,871 C .244
rs1540624 48,885,507 G .401
rs2302717 48,886,027 T .149
rs7191958 48,889,674 A .267
rs2302679 48,903,279 T .362
rs1872691 48,907,711 A .195
rs1064448 48,908,384 T .475
Males (1090 cases, 636 control subjects)
rs7202127 48,882,871 C .243
rs1540624 48,885,507 G .430
rs2302717 48,886,027 T .184
rs7191958 48,889,674 A .301
rs2302679 48,903,279 T .374
rs1872691 48,907,711 A .183
rs1064448 48,908,384 T .485
BP, base pair; CHISQ, Chi-squared test; CI, confidence interval; MAF
polymorphisms.
aAssociations attaining nominal significance (p .05).
bThose remaining significant after 10,000 permutations.
Table 3. LD Structure in Our Sample
rs7202127 rs1540624 rs2302717
rs7202127 1 .4 .08
rs1540624 .4 1 .29
rs2302717 .08 .29 1
rs7191958 .15 .05 .48
rs2302679 .04 .04 .24
rs1872691 .02 .06 .03
rs1064448 .12 .13 .01
2Values represent r values between the indicated pairs of single nucleotide p
LD, linkage disequilibrium.
ww.sobp.org/journaltrate a sex-specific role for this gene in voluntary alcohol con-
umption, the human genetic study identifies a genetic
olymorphism within the ADCY7 gene associating with alcohol
ependence in human female subjects. The results obtained in
ice support the interpretation that decreased levels of AC7
redispose to higher alcohol intake. This agrees with earlier
ndings linking decreased activity of the downstream cAMP/
KA/CREB pathway to high voluntary alcohol consumption in
odents. As noted in the preceding text, enhanced voluntary
lcohol consumption was found in mice lacking the regulatory
I subunit of PKA (11) or lacking CREB (9). Particularly, decreased
ctivity of this pathway in the nucleus accumbens was shown to
onfer high alcohol drinking. In light of our results, we would
ow like to extend this suggestion and propose that differences
n the expression of AC7, upstream of PKA, modify alcohol-
rinking behavior. This hypothesis might be consistent with the
act that AC7 is a selective target of alcohol (33,34), which in-
reases its activity.
The consumption of ethanol is the behavioral act that initi-
tes intoxication (with both positive and negative reinforcing
onsequences as well as aversive events). It is also the consump-
ion of ethanol in high quantities over periods that results in
euroadaptive changes that lead to signs of alcohol abuse and
ependence. Levels of alcohol consumption are statistically cor-
elated with the propensity to become dependent or stay de-
endent on alcohol (35), and the consumption of ethanol is a
l Subjects Major Allele CHISQ OR (95% CI) p
G .003 1.006 (.795–1.274) .9588
A 2.908 .8364 (.681–1.027) .0881
C 6.137 .7074 (.538–.931) .0132ab
G 4.266 .789 (.630–.988) .0389a
C .245 .9483 (.769–1.17) .6206
G 1.624 1.184 (.913–1.535) .2026
G .172 1.044 (.852–1.278) .6782
G .661 .936 (.798–1.098) .4162
A .497 .9511 (.827–1.093) .4807
C .137 1.034 (.864–1.238) .7117
G .662 .9398 (.809–1.092) .4159
C 1.815 1.104 (.956–1.275) .1779
G .425 1.062 (.886–1.273) .5143
G 1.712 1.097 (.955–1.26) .1907
or allele frequency; OR, estimated odds ratio; SNP, single nucleotide
rs7191958 rs2302679 rs1872691 rs1064448
.15 .04 .02 .12
.05 .04 .06 .13
.48 .24 .03 .01
1 .05 .05 .02
.05 1 .12 .1
.05 .12 1 .23
.02 .1 .23 1ontro
.243
.445
.198
.316
.374
.170
.464
.256
.443
.179
.314
.351
.174
.462
, minolymorphisms.
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S. Desrivières et al. BIOL PSYCHIATRY 2011;69:1100–1108 1105necessary (albeit maybe not sufficient) component of predispo-
sition to alcoholism in humans. Given these data and that animal
(rodent) models of alcohol dependence do not well-model (al-
though some claims have been made to this effect) the psychi-
Figure 2. Associations between alcohol dependence in females and single
ADCY7 Reference Sequence (RefSeq) on chromosome 16, generated from
Introns are displayed as thin lines between exons (thick marks). Arrowhe
polymorphisms investigated are indicated, with themarkermost significant
complete linkagedisequilibrium (LD) (r2
1)with rs230271 is also indicated.
(B) The LD structure around the ADCY7 locus is shown. Diamonds are colore
Markers genotyped in this study are highlighted in bold; those part of
dependence are underlined. Estimated recombination rates in (B) are fromH
browser with hg18 coordinates.
Figure 3. Correlation of rs2302717 genotypes with ADCY7 (NM_001114)
messenger RNA expression in adipose tissue (n
 606) and blood (n
 747)
samples. Data ( SEM) are expressed in standardized (inverse-normal trans-l
formed) and adjusted (for sex, age, and differential cell count) expression
levels.tric criteria (e.g., DSM-IV or ICD-10) of alcohol dependence
except for the hyperexcitability of alcohol withdrawal and tol-
rance), we currently believe that measuring drinking levels in
nimals provides a reasonable surrogate of predisposition to
lcohol dependence in humans and that a genetic marker that is
ssociated with differences in the quantity of alcohol consump-
ion in animals (including humans)might also be associatedwith
he presence of alcohol dependence in humans.
Previous studies have shown significantly lower receptor-
timulated AC activity in platelets and lymphocytes from absti-
ent alcoholic subjects compared with nonalcoholic subjects
16,36–38). Because both genetic factors and abstinence from
lcohol seem to have roles in determining low platelet AC activ-
ty (17,18,38), these data suggested that platelet AC activity
ould be a biochemical state or trait marker for alcohol depen-
ence. These observations suggested, given that the AC7 iso-
orm is expressed in human platelet precursor cells (39), that AC7
ight be associated with development and/or maintenance of
lcohol dependence in humans. Prior analysis of AC7 polymor-
hic repeats in 30 alcoholic and 17 control individuals failed to
eveal an association between AC7 variations and alcoholism
40). However, these repeats are in the 3= untranslated region of
DCY7, whereas the haplotype identified in our current work is in
he area of the gene transcription start site. Our current study
lso uses amuch larger sample of alcohol-dependent individuals
han the prior work (40), to allow robust investigation of ADCY7
n human alcohol dependence. Our expression quantitative trait
otide polymorphisms in the ADCY7 locus. (A) Genomic organization of the
rsity of California at Santa Cruz genome browser with hg19 coordinates.
how orientation of the gene on the chromosome. The single nucleotide
ociatedwith dependence (rs2302717) highlighted. Amarker (rs1078151) in
r lane indicates genomic coordinates (basepairs; hg19) on chromosome16.
white-to-red scale corresponding to r2 values from 0 to 1 with rs2302717.
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whol dependence in our study (rs2302717) and/or other SNPs in
LD (like rs1078151) affects ADCY7 expression. Presence of the
minor allele at rs2302717 is associated with lower levels of
ADCY7 mRNA levels in adipose tissue and particularly in blood.
Because lower levels of ADCY7 mRNA (assuming that mRNA
levels quantitatively reflect the levels of AC7 protein) would be
expected to be associated with higher alcohol drinking (on the
basis of our data with Adcy7/ mice and prior animal studies
described in the preceding text), it might seem counterintuitive
that the presence of the minor allele at rs2302717 is also associ-
ated with a reduced risk of alcohol dependence. Certainly, one
should determine the relation of the minor allele at rs2302717
and/or rs1078151 with ADCY7 mRNA levels in human brain tis-
sue, because genetic variation can affect gene expression in a
tissue- and cell-specific manner (41). The importance of tissue
type and sampling conditions for the effect of promoter variants
on gene expression has been repeatedly observed. A recent
example for such effects in various brain regions and blood is
provided by rs16147 at the NPY locus (42–44). Nongenetic fac-
tors might also influence ADCY7 expression. For example, an
explanation of the lower ADCY7 mRNA levels in humans might
well be linked to observations that alcohol intake can lower AC7
enzyme activity in blood (particularly platelets) (17). Both alco-
hol intake and recent abstinence (withdrawal) have been shown
to alter gene expression (45,46). Thus, the relation between
rs2302717 and ADCY7mRNAmight reflect the influence of other
factors, including alcohol-drinking history, on gene transcrip-
tion in individuals of a particular genotype. In other words, the
relation we report between the presence of the minor allele of
rs2302717 and tissue ADCY7 mRNA levels might be inherent
and/or reflect an interaction with other genetic and nongenetic
factors.
It was of interest to note that the female mice of the C57BL/6
strain increased their consumptionof ethanol primarily at the lower
concentrations, whereas the female 129 mice increased consump-
tion of the higher concentrations of ethanol. The C57BL/6 strain
normally prefers the higher concentrations of ethanol (10%) (47),
whereas the 129 strain normally shows avoidance of these concen-
trations (47). In essence, thegeneticmanipulation (lowering) ofAC7
in brain generates an increase in consumption of ethanol at con-
centrations at which the C57BL/6mice usually have little interest in
the ethanol solution, and 129 mice usually begin to avoid the eth-
anol solution. At concentrations above 10% ethanol, the C57BL/6
mice are reaching a ceiling with regard to their volume of ethanol
solution consumption, and themanipulation of AC7 cannot further
increase consumption.
Our observations point to a sex-specific role for AC7, both in
mice and humans, with main effects observed in female subjects.
Such sex-related differences might not be evident when the cAMP
signaling cascade is perturbed at other points. No differences be-
tween sexes inmeasures of ethanol consumptionwere observed in
mice lacking the regulatory II subunit of PKA (11).However, female
mutantmicedisplayeddecreasedoperant self-administrationcom-
pared with WT females, indicative of decreased reinforcement-
seeking behavior (48). Whether CREB deletion contributes to sex-
specific effects on alcohol consumption has not been investigated,
because only male mice were used for these studies (49). That the
CREB-deficient mice were also on a mixed C57BL/6 and 129/SVJ
background might also influence the measurements of alcohol
consumption levels, compared with males on an isogenic back-
ground. Nonetheless, our results reveal a special relevance for AC7
in female alcohol-related behavior.The sex differences observed in our experiments might not
ww.sobp.org/journale surprising, considering the signaling crosstalk between the
AMP/PKA pathway and steroid receptors. Recent experiments
ave demonstrated that elevated levels of cAMP lead to ligand-
ndependent activation of the estrogen receptor through PKA
50,51). Conversely, acute and long-term treatments with estro-
ens have been shown to increase CREB-DNA binding in brain
reas linked to affective and cognitive behaviors, like the
mygdala and the frontal cortex (52). In line with this, several
tudies have reported associations between polymorphisms in
he estrogen receptor  gene (ERS1) and anxiety in humans
53–55). However, whether such polymorphisms produce differ-
ntial interaction with components of the cAMP signaling sys-
em and also contribute to sex differences in alcohol use and
ependence (56) remains to be tested.
Taken together, our results solidify the notion that the cAMP
athway functions in a sex-specific manner to influence alcohol-
elated behavioral events. We have shown that AC7 is an important
C isoform in mediating the cAMP influence on alcohol-drinking–
elated behaviors in mice. Our work with humans provides for a
ex-specific association of AC7 polymorphisms and alcohol depen-
ence. Further understanding of the regulation of AC7 activity and
xpression will help provide a better understanding of the AC7-
ependent pathways that predispose to alcoholism.
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